元数据阅读
当前来源没有提供可抓取的公开正文，系统只能展示标题、摘要、来源链接和核验信息。
摘要
NCT ID: NCT05175235 | PHASE1, PHASE2 | Solid Tumor
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
NCT ID: NCT05175235 | PHASE1, PHASE2 | Solid Tumor